Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

Proceedings of the National Academy of Sciences of the United States of America
Jianhua SuiWayne A Marasco


Effective prophylaxis and antiviral therapies are urgently needed in the event of reemergence of the highly contagious and often fatal severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) infection. We have identified eight recombinant human single-chain variable region fragments (scFvs) against the S1 domain of spike (S) protein of the SARS-CoV from two nonimmune human antibody libraries. One scFv 80R efficiently neutralized SARS-CoV and inhibited syncytia formation between cells expressing the S protein and those expressing the SARS-CoV receptor angiotensin-converting enzyme 2 (ACE2). Mapping of the 80R epitope showed it is located within the N-terminal 261-672 amino acids of S protein and is not glycosylation-dependent. 80R scFv competed with soluble ACE2 for association with the S1 domain and bound S1 with high affinity (equilibrium dissociation constant, Kd=32.3 nM). A human IgG1 form of 80R bound S1 with a 20-fold higher affinity of 1.59 nM comparable to that of ACE2 (Kd=1.70 nM), and neutralized virus 20-fold more efficiently than the 80R scFv. These data suggest that the 80R human monoclonal antibody may be a useful viral entry inhibitor for the emergency prophylaxis and treatment of SARS, and that the ACE2-b...Continue Reading


Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·R K WilliamsK V Holmes
Jan 1, 1996·Methods in Enzymology·J L HarrisonA Nissim
May 1, 1995·Immunotechnology : an International Journal of Immunological Engineering·R SchierL M Weiner
Oct 12, 2000·Clinical Microbiology Reviews·M A Keller, E R Stiehm
Feb 13, 2001·Virology·T M Gallagher, M J Buchmeier
Apr 11, 2001·Advances in Immunology·P W Parren, D R Burton
Feb 1, 2002·Nature Biotechnology·Arturo Casadevall
Sep 5, 2002·Nature Reviews. Immunology·Dennis R Burton
Oct 29, 2002·The Journal of Biological Chemistry·Jirong BaiWayne A Marasco
Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
May 16, 2003·The New England Journal of Medicine·Kathryn V Holmes
Jun 5, 2003·The Journal of Clinical Investigation·Kathryn V Holmes
Jul 11, 2003·Nature·Helen PearsonDavid Cyranoski
Aug 2, 2003·The New England Journal of Medicine·Gang LiAnlong Xu
Sep 27, 2003·Biochemical and Biophysical Research Communications·Ottavia SpigaNeri Niccolai

❮ Previous
Next ❯


Sep 21, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S T Lai
Jul 11, 2009·Bulletin of Mathematical Biology·Ying-Hen HsiehMei-Shang Ho
Jul 21, 2007·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Li QinQiping Lin
Jun 14, 2005·Current Opinion in Immunology·Yu Lung Lau, J S Malik Peiris
Mar 8, 2005·Drug Discovery Today·Yossef KligerDoron Gerber
Mar 16, 2005·The Lancet Infectious Diseases·David A GronebergPeter Zabel
May 5, 2011·Journal of Chemical Information and Modeling·Luis F PaciosAraceli Díaz-Perales
Dec 11, 2007·Nature Biotechnology·Wayne A Marasco, Jianhua Sui
Dec 4, 2004·Nature Medicine·J S M PeirisK Y Yuen
Feb 10, 2009·Nature Reviews. Microbiology·Lanying DuShibo Jiang
Sep 17, 2004·Nature Reviews. Microbiology·Erik De Clercq
Feb 24, 2009·Nature Structural & Molecular Biology·Jianhua SuiWayne A Marasco
Aug 20, 2004·The New England Journal of Medicine·Robert W Doms
Dec 7, 2007·Biotechnology & Genetic Engineering Reviews·Robert C Ladner
Oct 19, 2010·Avian Pathology : Journal of the W.V.P.A·Sameer A GreenallSandra I Sapats
Nov 17, 2005·Journal of Neurovirology·Samson S Y Wong, K Y Yuen
Jan 12, 2011·The Journal of Experimental Medicine·Jens WrammertPatrick C Wilson
Jun 15, 2007·Antioxidants & Redox Signaling·Emmanuel FenouilletIan M Jones
Jul 23, 2005·Viral Immunology·Yuxian He, Shibo Jiang
Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jianhua SuiWayne A Marasco
Mar 3, 2010·Molecular Biology and Evolution·Teruaki Watabe, Hirohisa Kishino
Oct 30, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jiping ZhangJonathan D Cheng
Oct 17, 2006·Clinical Microbiology Reviews·Laura Gillim-Ross, Kanta Subbarao
Oct 16, 2007·Clinical Microbiology Reviews·Vincent C C ChengKwok Yung Yuen
Apr 11, 2008·Clinical Microbiology Reviews·W Garrett NicholsMichael Boeckh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.


Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.